DAVE241220C105000
- 0.04
- 0.000.00%
Dave Inc Newsroom
Institutional Investors in Dave Inc. (NASDAQ:DAVE) Lost 8.1% Last Week but Have Reaped the Benefits of Longer-term Growth
8 Analysts Have This To Say About Dave
Dave Price Target Maintained With a $119.00/Share by Benchmark
Dave Analyst Ratings
Benchmark Co. Maintains Dave Inc(DAVE.US) With Buy Rating, Maintains Target Price $119
Is DAVE INC (DAVE) Outperforming Other Business Services Stocks This Year?
Sector Update: Financial Stocks Mixed Tuesday Afternoon
Top Midday Decliners
Top Midday Stories: Sangamo Shares Fall After Pfizer Exits Collaboration; Dave Denies DOJ Allegations
Lake Street Maintains Dave Inc(DAVE.US) With Buy Rating, Maintains Target Price $98
Sector Update: Tech Stocks Advance Premarket Tuesday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Last Trading Day of 2024
Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Sector Update: Tech
Dave Denies Wrongdoing in DOJ Complaint
Dave Explains FTC Complaint Amendment; Changes ExtraCash Fee Structure
Express News | Dave Shares Down 7.3% Premarket After U.S. Justice Department Files Complaint Against Co and CEO
Dave Inc. Says Company's Outlook Remains Positive, And It Looks Forward To Sharing Results And More Substantive Update During Q4 Earnings Call In Early March
Express News | Dave Inc: Expects to Complete Full Implementation of New Fee Structure in Early 2025
Express News | Dave Inc: Issues Statement in Response to Amended FTC Complaint